Aytu BioPharmaAYTU stock fell by 8.33% on Tuesday after the company reported its Q4 earnings results on Monday, September 27, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Aytu BioPharma missed their estimated earnings by 65.31%, which surprised analysts.
Revenue was up $8,621,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $-0.12, which was followed by a 3.21% drop in the share price the next day.
Here's a look at Aytu BioPharma's past performance and the resulting price change:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|
| EPS Estimate | -0.49 | -0.31 | -0.44 | -0.05 | -0.03 |
| EPS Actual | -0.81 | -0.43 | -0.70 | -0.04 | -0.02 |
| Price Change % | -8.33% | -3.21% | -1.95% | -5.9% | -12.78% |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
